Fulgent Forecasts 2024 Core Revenue Of Approximately $280M Versus Consensus Of $279.356M, With Adjusted EPS Loss Of Approximately $(1.05) Versus Consensus Of $(1.06)
Portfolio Pulse from Benzinga Newsdesk
Fulgent Genetics (FLGT) projects its 2024 core revenue to be around $280 million, slightly above the consensus estimate of $279.356 million. The company also forecasts an adjusted EPS loss of approximately $(1.05), which is marginally better than the consensus estimate of $(1.06).
May 03, 2024 | 11:05 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Fulgent Genetics (FLGT) projects a 2024 core revenue of $280M, slightly above consensus, and an adjusted EPS loss better than expected at $(1.05).
Fulgent Genetics' projection of higher-than-expected revenue and a smaller-than-anticipated adjusted EPS loss for 2024 could positively influence investor sentiment and potentially lead to a short-term uptick in FLGT's stock price. The slight outperformance compared to consensus estimates indicates operational efficiency and could attract investor interest.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100